379 related articles for article (PubMed ID: 35432217)
1. Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.
Gado M; Baschant U; Hofbauer LC; Henneicke H
Front Endocrinol (Lausanne); 2022; 13():835720. PubMed ID: 35432217
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids and bone: local effects and systemic implications.
Henneicke H; Gasparini SJ; Brennan-Speranza TC; Zhou H; Seibel MJ
Trends Endocrinol Metab; 2014 Apr; 25(4):197-211. PubMed ID: 24418120
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast autophagy in glucocorticoid-induced osteoporosis.
Wang L; Heckmann BL; Yang X; Long H
J Cell Physiol; 2019 Apr; 234(4):3207-3215. PubMed ID: 30417506
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced osteoporosis and osteonecrosis.
Weinstein RS
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):595-611. PubMed ID: 22877431
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
Mazziotti G; Giustina A; Canalis E; Bilezikian JP
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1404-12. PubMed ID: 18209880
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
Canalis E; Mazziotti G; Giustina A; Bilezikian JP
Osteoporos Int; 2007 Oct; 18(10):1319-28. PubMed ID: 17566815
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
[TBL] [Abstract][Full Text] [Related]
8. The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells.
Hong D; Chen HX; Ge RS; Li JC
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):164-70. PubMed ID: 18644452
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
Wang T; Yu X; He C
Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms of glucocorticoid-induced osteoporosis.
Chen M; Fu W; Xu H; Liu CJ
Cytokine Growth Factor Rev; 2023 Apr; 70():54-66. PubMed ID: 36906448
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced osteoporosis: an update.
Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.
Lane NE
Curr Osteoporos Rep; 2019 Feb; 17(1):1-7. PubMed ID: 30685820
[TBL] [Abstract][Full Text] [Related]
14. Osteocyte biology: its implications for osteoporosis.
Bonewald LF
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):101-4. PubMed ID: 15615083
[TBL] [Abstract][Full Text] [Related]
15. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone.
Piemontese M; Onal M; Xiong J; Wang Y; Almeida M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
Bone; 2015 Jun; 75():18-26. PubMed ID: 25700544
[TBL] [Abstract][Full Text] [Related]
16. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced osteoporosis: an update on effects and management.
Buehring B; Viswanathan R; Binkley N; Busse W
J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Weinstein RS; Jilka RL; Parfitt AM; Manolagas SC
J Clin Invest; 1998 Jul; 102(2):274-82. PubMed ID: 9664068
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
Chotiyarnwong P; McCloskey EV
Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
[TBL] [Abstract][Full Text] [Related]
20. [Glucocorticoid and bone metabolism and disease].
Tanaka Y
Clin Calcium; 2013 Feb; 23(2):229-35. PubMed ID: 23354090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
